Prevalence and predictive factors of complementary medicine use during the first wave of the COVID-19 pandemic of 2020 in the Netherlands.

Mulder, Louise T C; Busch, Martine; Kristoffersen, Agnete E; Hök Nordberg, Johanna; van der Werf, Esther T

Mulder, Louise T C; Busch, Martine; Kristoffersen, Agnete E; Hök Nordberg, Johanna; van der Werf, Esther T.

Afiliação

Mulder LTC; Louis Bolk Institute, Kosterijland 3-5, 3981 AJ, Bunnik, The Netherlands.
Busch M; Van Praag Institute, Springweg 7, 3511 VH, Utrecht, The Netherlands.
Kristoffersen AE; Dutch Consortium for Integrative Medicine and Health (CIZG), Utrecht, The Netherlands.
Hök Nordberg J; National Research Centre in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
van der Werf ET; Regional Cancer Centre Stockholm Gotland, Stockholm, Sweden.

BMC Complement Med Ther ; 22(1): 43, 2022 Feb 15.

Article em En | MEDLINE | ID: mdl-35168630

Assuntos

COVID-19; Terapias Complementares; Adulto; Feminino; Humanos; Países Baixos/epidemiologia; Pandemias; Prevalência; SARS-CoV-2

Palavras-chave

CM provider; Prevalence; Self-care techniques; Self-management strategies; Survey; The Netherlands

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapias Complementares / COVID-19 Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Revista: BMC Complement Med Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google